Cargando…

Differential methylation at MHC in CD4(+) T cells is associated with multiple sclerosis independently of HLA-DRB1

BACKGROUND: Although many genetic variants have been associated with multiple sclerosis (MS) risk, they do not explain all the disease risk and there remains uncertainty as to how these variants contribute to disease. DNA methylation is an epigenetic mechanism that can influence gene expression and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maltby, Vicki E., Lea, Rodney A., Sanders, Katherine A., White, Nicole, Benton, Miles C., Scott, Rodney J., Lechner-Scott, Jeannette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516341/ https://www.ncbi.nlm.nih.gov/pubmed/28729889 http://dx.doi.org/10.1186/s13148-017-0371-1

Ejemplares similares

Genome-wide DNA methylation changes in CD19(+) B cells from relapsing-remitting multiple sclerosis patients
por: Maltby, Vicki E., et al.
Publicado: (2018)

Genome-wide DNA methylation profiling of CD8+ T cells shows a distinct epigenetic signature to CD4+ T cells in multiple sclerosis patients
por: Maltby, Vicki E., et al.
Publicado: (2015)

DNA methylation changes in CD4(+) T cells isolated from multiple sclerosis patients on dimethyl fumarate
por: Maltby, Vicki E, et al.
Publicado: (2018)

Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells
por: Sanders, Katherine A., et al.
Publicado: (2016)

Letter to the editor: blood processing and sample storage have negligible effects on methylation
por: Groen, Kira, et al.
Publicado: (2018)

Erythrocytes in multiple sclerosis – forgotten contributors to the pathophysiology?
por: Groen, Kira, et al.
Publicado: (2016)

Capturing SNP Association across the NK Receptor and HLA Gene Regions in Multiple Sclerosis by Targeted Penalised Regression Models
por: Burnard, Sean M., et al.
Publicado: (2021)

Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis
por: Groen, Kira, et al.
Publicado: (2018)

Whole-blood methylation signatures are associated with and accurately classify multiple sclerosis disease severity
por: Campagna, Maria Pia, et al.
Publicado: (2022)

The effect of cladribine on immunoglobulin levels compared to B cell targeting therapies in multiple sclerosis
por: Lycett, Mitchell J, et al.
Publicado: (2023)

Erythrocyte microRNAs show biomarker potential and implicate multiple sclerosis susceptibility genes
por: Groen, Kira, et al.
Publicado: (2020)

Parity is associated with long-term differences in DNA methylation at genes related to neural plasticity in multiple sclerosis
por: Campagna, Maria Pia, et al.
Publicado: (2023)

Epigenetic differences at the HTR2A locus in progressive multiple sclerosis patients
por: Maltby, Vicki E., et al.
Publicado: (2020)

DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and Monocytes
por: Xavier, Alexandre, et al.
Publicado: (2023)

Increased DNA methylation of SLFN12 in CD4(+) and CD8(+) T cells from multiple sclerosis patients
por: Rhead, Brooke, et al.
Publicado: (2018)

Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis
por: Xavier, Alexandre, et al.
Publicado: (2023)

HLA-A Confers an HLA-DRB1 Independent Influence on the Risk of Multiple Sclerosis
por: Brynedal, Boel, et al.
Publicado: (2007)

A comparison between the pathophysiology of multiple sclerosis and normal pressure hydrocephalus: is pulse wave encephalopathy a component of MS?
por: Bateman, Grant A., et al.
Publicado: (2016)

Expression of the Multiple Sclerosis-Associated MHC Class II Allele HLA-DRB1*1501 Is Regulated by Vitamin D
por: Ramagopalan, Sreeram V., et al.
Publicado: (2009)

Epigenome-wide association studies: current knowledge, strategies and recommendations
por: Campagna, Maria Pia, et al.
Publicado: (2021)

Evaluation of Cell-Specific Epigenetic Age Acceleration in People With Multiple Sclerosis
por: Maltby, Vicki, et al.
Publicado: (2023)

Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study)
por: Maltby, Vicki E, et al.
Publicado: (2021)

2D in-vivo L-COSY spectroscopy identifies neurometabolite alterations in treated multiple sclerosis
por: Quadrelli, Scott, et al.
Publicado: (2019)

HLA-DRB1(∗)0401 and HLA-DRB1(∗)0408 Are Strongly Associated with the Development of Antibodies against Interferon-β Therapy in Multiple Sclerosis
por: Hoffmann, Steve, et al.
Publicado: (2008)

Can a stress management programme reduce stress and improve quality of life in people diagnosed with multiple sclerosis?
por: Agland, Susan, et al.
Publicado: (2018)

DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis
por: Kular, Lara, et al.
Publicado: (2018)

Critical evaluation of linear regression models for cell-subtype specific methylation signal from mixed blood cell DNA
por: Kennedy, Daniel W., et al.
Publicado: (2018)

HLA DRB101 and macrophagic myofasciitis
por: Guis, S, et al.
Publicado: (2003)

Association of HLA-DR2-Related Haplotype (HLA-DRB5*01-DRB1*1501-DQB1*0602) in Patients with Multiple Sclerosis in Khuzestan Province
por: DELFAN, Nooshin, et al.
Publicado: (2021)

Multiple Sclerosis Risk Variant HLA-DRB1*1501 Associates with High Expression of DRB1 Gene in Different Human Populations
por: Alcina, Antonio, et al.
Publicado: (2012)

HLA-DRB1 allele impact on pediatric multiple sclerosis in a Hellenic cohort
por: Gontika, Maria, et al.
Publicado: (2020)

Association of HLA-DRB1*11 and HLA-DRB1*12 gene polymorphism with COVID-19 in Burkina Faso
por: Ouedraogo, Alfred Rakissida, et al.
Publicado: (2023)

A Major Histocompatibility Class I Locus Contributes to Multiple Sclerosis Susceptibility Independently from HLA-DRB1*15:01
por: Cree, Bruce A. C., et al.
Publicado: (2010)

Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study
por: Nakamura, Yuri, et al.
Publicado: (2016)

HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis
por: Ombrello, M, et al.
Publicado: (2015)

Accounting for cell lineage and sex effects in the identification of cell-specific DNA methylation using a Bayesian model selection algorithm
por: White, Nicole, et al.
Publicado: (2017)

HLA-DRB1-DQB1 Haplotypes Confer Susceptibility and Resistance to Multiple Sclerosis in Sardinia
por: Cocco, Eleonora, et al.
Publicado: (2012)

Interaction between HLA-DRB1-DQB1 Haplotypes in Sardinian Multiple Sclerosis Population
por: Cocco, Eleonora, et al.
Publicado: (2013)

HLA-DRB1*14 is a protective allele for multiple sclerosis in an admixed Colombian population
por: Toro, Jaime, et al.
Publicado: (2015)

Complex relation of HLA-DRB1*1501, age at menarche, and age at multiple sclerosis onset
por: Bove, Riley, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_oq5k64aclu01pu18670ldn0ref